83/100B413.00
USD
1.73
(0.42%)
Market Open
Last updated: · Delayed 15 min
Fair value379.45Plus+9%222Price 413.00531
Q4 FY2026 · Earnings report
EPS estimate 2.27Revenue estimate 825.22M
Q4 FY2026 · Earnings report
EPS estimate 2.27Revenue estimate 825.22M
West Pharmaceutical Services price to sales (P/S) ratioWhat is the P/S ratio? The price-to-sales ratio compares a company's market value with its revenue over the last year: what you pay for each dollar of sales.
West Pharmaceutical Services's P/S ratio is 8.47: its market cap of 28.77B USD over revenue of 3.40B USD in the last twelve months.
- Today
- 8.47
- Average, 5 years
- 7.91
- Low, 5 years
- 4.80
- High, 5 years
- 13.03
P/S ratio = market cap ÷ revenue (last 12 months) = 28.77B ÷ 3.40B = 8.47
Each day's market cap over the revenue of the last four quarters reported by that day.
P/S ratio by year and by quarter
| Fiscal year | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Today | 8.47 | 28.77B | 3.40B | |
| FY2025 | 31 Dec 2025 | 6.47 | 19.89B | 3.07B |
| FY2024 | 31 Dec 2024 | 8.27 | 23.91B | 2.89B |
| FY2023 | 31 Dec 2023 | 8.87 | 26.16B | 2.95B |
| FY2022 | 31 Dec 2022 | 6.07 | 17.51B | 2.89B |
| FY2021 | 31 Dec 2021 | 12.33 | 34.89B | 2.83B |
| FY2020 | 31 Dec 2020 | 9.75 | 20.94B | 2.15B |
| FY2019 | 31 Dec 2019 | 6.03 | 11.12B | 1.84B |
| FY2018 | 31 Dec 2018 | 4.22 | 7.24B | 1.72B |
| FY2017 | 31 Dec 2017 | 4.56 | 7.29B | 1.60B |
| FY2016 | 31 Dec 2016 | 4.12 | 6.22B | 1.51B |
| FY2015 | 31 Dec 2015 | 3.10 | 4.34B | 1.40B |
| FY2014 | 31 Dec 2014 | 2.66 | 3.77B | 1.42B |
| FY2013 | 31 Dec 2013 | 2.50 | 3.41B | 1.37B |
| FY2012 | 31 Dec 2012 | 1.47 | 1.86B | 1.27B |
| FY2011 | 31 Dec 2011 | 1.07 | 1.28B | 1.19B |
| FY2010 | 31 Dec 2010 | 1.24 | 1.37B | 1.10B |
| FY2009 | 31 Dec 2009 | 1.22 | 1.29B | 1.06B |
| FY2008 | 31 Dec 2008 | 1.16 | 1.22B | 1.05B |
| FY2007 | 31 Dec 2007 | 1.30 | 1.33B | 1.02B |
| FY2006 | 31 Dec 2006 | 1.81 | 1.65B | 913.30M |
| FY2005 | 31 Dec 2005 | 1.11 | 778.74M | 699.70M |
| FY2004 | 31 Dec 2004 | 1.39 | 751.20M | 541.60M |
| FY2003 | 31 Dec 2003 | 1.00 | 491.26M | 490.70M |
| FY2002 | 31 Dec 2002 | 0.84 | 352.58M | 419.70M |
| FY2001 | 31 Dec 2001 | 0.96 | 381.34M | 396.90M |
| FY2000 | 31 Dec 2000 | 0.82 | 353.84M | 430.10M |
| FY1999 | 31 Dec 1999 | 0.98 | 461.14M | 469.10M |
| FY1998 | 31 Dec 1998 | 1.30 | 586.40M | 449.70M |
| FY1997 | 31 Dec 1997 | 1.08 | 490.30M | 452.50M |
| FY1996 | 31 Dec 1996 | 1.01 | 463.64M | 458.80M |
| FY1995 | 31 Dec 1995 | 0.94 | 389.42M | 412.90M |
| FY1994 | 31 Dec 1994 | 1.21 | 441.81M | 365.10M |
| FY1993 | 31 Dec 1993 | 1.12 | 389.34M | 348.70M |
| FY1992 | 31 Dec 1992 | 1.04 | 352.10M | 338.20M |
| FY1991 | 31 Dec 1991 | 0.87 | 288.07M | 329.60M |
| FY1990 | 31 Dec 1990 | 0.60 | 194.93M | 323.20M |
| FY1989 | 31 Dec 1989 | 1.00 | 307.27M | 308.70M |
| FY1988 | 31 Dec 1988 | 0.85 | 243.93M | 288.20M |
| FY1987 | 31 Dec 1987 | 1.07 | 270.13M | 253.30M |
| FY1986 | 31 Dec 1986 | 0.96 | 226.45M | 235.60M |
| FY1985 | 31 Dec 1985 | 1.07 | 204.00M | 190.10M |
| Quarter | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 7.68 | 26.10B | 3.40B |
| Q2 FY2026 | 30 Jun 2026 | 7.64 | 25.42B | 3.33B |
| Q1 FY2026 | 31 Mar 2026 | 5.60 | 18.05B | 3.22B |
| Q4 FY2025 | 31 Dec 2025 | 6.47 | 19.89B | 3.07B |
| Q3 FY2025 | 30 Sept 2025 | 6.29 | 18.97B | 3.02B |
| Q2 FY2025 | 30 Jun 2025 | 5.34 | 15.82B | 2.96B |
| Q1 FY2025 | 31 Mar 2025 | 5.61 | 16.23B | 2.90B |
| Q4 FY2024 | 31 Dec 2024 | 8.27 | 23.91B | 2.89B |
| Q3 FY2024 | 30 Sept 2024 | 7.60 | 21.85B | 2.88B |
| Q2 FY2024 | 30 Jun 2024 | 8.24 | 23.69B | 2.88B |
| Q1 FY2024 | 31 Mar 2024 | 9.94 | 29.10B | 2.93B |
| Q4 FY2023 | 31 Dec 2023 | 8.85 | 26.09B | 2.95B |
| Q3 FY2023 | 30 Sept 2023 | 9.53 | 27.88B | 2.93B |
| Q2 FY2023 | 30 Jun 2023 | 9.92 | 28.42B | 2.86B |
| Q1 FY2023 | 31 Mar 2023 | 8.96 | 25.81B | 2.88B |
| Q4 FY2022 | 31 Dec 2022 | 6.07 | 17.51B | 2.89B |
| Q3 FY2022 | 30 Sept 2022 | 6.30 | 18.31B | 2.91B |
| Q2 FY2022 | 30 Jun 2022 | 7.69 | 22.50B | 2.93B |
| Q1 FY2022 | 31 Mar 2022 | 10.61 | 30.56B | 2.88B |
| Q4 FY2021 | 31 Dec 2021 | 12.34 | 34.94B | 2.83B |
| Q3 FY2021 | 30 Sept 2021 | 11.73 | 31.46B | 2.68B |
| Q2 FY2021 | 30 Jun 2021 | 10.53 | 26.57B | 2.52B |
| Q1 FY2021 | 31 Mar 2021 | 8.95 | 20.82B | 2.33B |
| Q4 FY2020 | 31 Dec 2020 | 9.77 | 20.96B | 2.15B |
| Q3 FY2020 | 30 Sept 2020 | 9.95 | 20.32B | 2.04B |
| Q2 FY2020 | 30 Jun 2020 | 8.60 | 16.77B | 1.95B |
| Q1 FY2020 | 31 Mar 2020 | 5.95 | 11.25B | 1.89B |
| Q4 FY2019 | 31 Dec 2019 | 6.04 | 11.14B | 1.84B |
| Q3 FY2019 | 30 Sept 2019 | 5.86 | 10.49B | 1.79B |
| Q2 FY2019 | 30 Jun 2019 | 5.20 | 9.19B | 1.77B |
| Q1 FY2019 | 31 Mar 2019 | 4.75 | 8.28B | 1.75B |
| Q4 FY2018 | 31 Dec 2018 | 4.22 | 7.24B | 1.72B |
| Q3 FY2018 | 30 Sept 2018 | 5.31 | 9.09B | 1.71B |
| Q2 FY2018 | 30 Jun 2018 | 4.35 | 7.31B | 1.68B |
| Q1 FY2018 | 31 Mar 2018 | 4.01 | 6.52B | 1.63B |
| Q4 FY2017 | 31 Dec 2017 | 4.58 | 7.32B | 1.60B |
| Q3 FY2017 | 30 Sept 2017 | 4.56 | 7.14B | 1.57B |
| Q2 FY2017 | 30 Jun 2017 | 4.52 | 6.99B | 1.54B |
| Q1 FY2017 | 31 Mar 2017 | 3.90 | 5.98B | 1.53B |
| Q4 FY2016 | 31 Dec 2016 | 4.12 | 6.21B | 1.51B |
| Q3 FY2016 | 30 Sept 2016 | 3.67 | 5.46B | 1.49B |
| Q2 FY2016 | 30 Jun 2016 | 3.82 | 5.56B | 1.45B |
| Q1 FY2016 | 31 Mar 2016 | 3.52 | 5.03B | 1.43B |
| Q4 FY2015 | 31 Dec 2015 | 3.11 | 4.35B | 1.40B |
| Q3 FY2015 | 30 Sept 2015 | 2.81 | 3.91B | 1.39B |
| Q2 FY2015 | 30 Jun 2015 | 2.98 | 4.18B | 1.40B |
| Q1 FY2015 | 31 Mar 2015 | 3.06 | 4.32B | 1.41B |
| Q4 FY2014 | 31 Dec 2014 | 2.67 | 3.80B | 1.42B |
| Q3 FY2014 | 30 Sept 2014 | 2.25 | 3.18B | 1.41B |
| Q2 FY2014 | 30 Jun 2014 | 2.13 | 2.99B | 1.40B |
| Q1 FY2014 | 31 Mar 2014 | 2.26 | 3.11B | 1.38B |
| Q4 FY2013 | 31 Dec 2013 | 2.51 | 3.44B | 1.37B |
| Q3 FY2013 | 30 Sept 2013 | 2.13 | 2.87B | 1.35B |
| Q2 FY2013 | 30 Jun 2013 | 1.90 | 2.48B | 1.31B |
| Q1 FY2013 | 31 Mar 2013 | 1.69 | 2.19B | 1.29B |
| Q4 FY2012 | 31 Dec 2012 | 1.48 | 1.87B | 1.27B |
| Q3 FY2012 | 30 Sept 2012 | 1.49 | 1.84B | 1.24B |
| Q2 FY2012 | 30 Jun 2012 | 1.40 | 1.72B | 1.23B |
| Q1 FY2012 | 31 Mar 2012 | 1.19 | 1.44B | 1.21B |
| Q4 FY2011 | 31 Dec 2011 | 1.08 | 1.29B | 1.19B |
| Q3 FY2011 | 30 Sept 2011 | 1.07 | 1.25B | 1.17B |
| Q2 FY2011 | 30 Jun 2011 | 1.28 | 1.47B | 1.15B |
| Q1 FY2011 | 31 Mar 2011 | 1.33 | 1.50B | 1.13B |
| Q4 FY2010 | 31 Dec 2010 | 1.25 | 1.38B | 1.10B |
| Q3 FY2010 | 30 Sept 2010 | 1.02 | 1.15B | 1.12B |
| Q2 FY2010 | 30 Jun 2010 | 1.10 | 1.22B | 1.11B |
| Q1 FY2010 | 31 Mar 2010 | 1.28 | 1.39B | 1.09B |
| Q4 FY2009 | 31 Dec 2009 | 1.23 | 1.30B | 1.06B |
| Q3 FY2009 | 30 Sept 2009 | 1.33 | 1.34B | 1.01B |
| Q2 FY2009 | 30 Jun 2009 | 1.14 | 1.14B | 1.00B |
| Q1 FY2009 | 31 Mar 2009 | 1.05 | 1.07B | 1.02B |
| Q4 FY2008 | 31 Dec 2008 | 1.18 | 1.24B | 1.05B |
| Q3 FY2008 | 30 Sept 2008 | 1.49 | 1.59B | 1.06B |
| Q2 FY2008 | 5 Aug 2008 | — | 1.66B | — |
| Q1 FY2008 | 31 Mar 2008 | 1.38 | 1.42B | 1.03B |
| Q4 FY2007 | 31 Dec 2007 | 1.28 | 1.31B | 1.02B |
| Q3 FY2007 | 30 Sept 2007 | 1.36 | 1.35B | 995.90M |
| Q2 FY2007 | 30 Jun 2007 | 1.60 | 1.55B | 971.60M |
| Q1 FY2007 | 31 Mar 2007 | 1.60 | 1.52B | 948.10M |
| Q4 FY2006 | 31 Dec 2006 | 1.83 | 1.68B | 913.30M |
| Q3 FY2006 | 30 Sept 2006 | 1.44 | 1.26B | 877.10M |
| Q2 FY2006 | 30 Jun 2006 | 1.38 | 1.16B | 840.30M |
| Q1 FY2006 | 31 Mar 2006 | 1.42 | 1.10B | 773.10M |
| Q4 FY2005 | 31 Dec 2005 | 1.14 | 795.12M | 699.80M |
| Q3 FY2005 | 30 Sept 2005 | 1.46 | 929.99M | 638.70M |
| Q2 FY2005 | 30 Jun 2005 | 1.47 | 869.24M | 592.40M |
| Q1 FY2005 | 31 Mar 2005 | 1.31 | 732.42M | 557.50M |
| Q4 FY2004 | 31 Dec 2004 | 1.42 | 767.35M | 541.60M |
| Q3 FY2004 | 30 Sept 2004 | 1.18 | 629.39M | 533.40M |
| Q2 FY2004 | 30 Jun 2004 | 1.22 | 633.11M | 518.20M |
| Q1 FY2004 | 31 Mar 2004 | 1.09 | 550.60M | 506.50M |
| Q4 FY2003 | 31 Dec 2003 | 1.02 | 498.78M | 490.70M |
| Q3 FY2003 | 30 Sept 2003 | 0.97 | 454.33M | 467.70M |
| Q2 FY2003 | 30 Jun 2003 | 0.78 | 355.12M | 452.50M |
| Q1 FY2003 | 31 Mar 2003 | 0.65 | 283.81M | 433.80M |
| Q4 FY2002 | 31 Dec 2002 | 0.84 | 353.31M | 419.70M |
| Q3 FY2002 | 30 Sept 2002 | 0.85 | 310.09M | 366.90M |
| Q2 FY2002 | 30 Jun 2002 | 1.18 | 443.87M | 374.90M |
| Q1 FY2002 | 31 Mar 2002 | 1.12 | 430.98M | 384.40M |
| Q4 FY2001 | 31 Dec 2001 | 0.96 | 382.14M | 396.90M |
| Q3 FY2001 | 30 Sept 2001 | 0.77 | 348.82M | 451.50M |
| Q2 FY2001 | 30 Jun 2001 | 0.87 | 387.07M | 443.10M |
| Q1 FY2001 | 31 Mar 2001 | 0.76 | 334.52M | 438.60M |
| Q4 FY2000 | 31 Dec 2000 | 0.82 | 351.70M | 430.10M |
| Q3 FY2000 | 30 Sept 2000 | 0.76 | 333.19M | 440.30M |
| Q2 FY2000 | 30 Jun 2000 | 0.69 | 312.98M | 450.90M |
| Q1 FY2000 | 31 Mar 2000 | 0.80 | 368.30M | 462.60M |
| Q4 FY1999 | 31 Dec 1999 | 0.96 | 449.76M | 469.10M |
| Q3 FY1999 | 30 Sept 1999 | 1.20 | 562.26M | 468.50M |
| Q2 FY1999 | 30 Jun 1999 | 1.25 | 582.99M | 467.30M |
| Q1 FY1999 | 31 Mar 1999 | 1.05 | 480.73M | 458.70M |
| Q4 FY1998 | 31 Dec 1998 | 1.20 | 538.03M | 449.70M |
| Q3 FY1998 | 30 Sept 1998 | 1.11 | 491.95M | 444.40M |
| Q2 FY1998 | 30 Jun 1998 | 1.11 | 483.39M | 435.70M |
| Q1 FY1998 | 31 Mar 1998 | 1.13 | 498.63M | 443.00M |
| Q4 FY1997 | 31 Dec 1997 | 1.08 | 488.27M | 452.50M |
| Q3 FY1997 | 30 Sept 1997 | 1.19 | 543.71M | 457.60M |
| Q2 FY1997 | 30 Jun 1997 | 1.02 | 474.20M | 463.70M |
| Q1 FY1997 | 31 Mar 1997 | 0.97 | 446.68M | 459.60M |
| Q4 FY1996 | 31 Dec 1996 | 1.01 | 465.13M | 458.80M |
| Q3 FY1996 | 30 Sept 1996 | 0.95 | 427.02M | 451.80M |
| Q2 FY1996 | 30 Jun 1996 | 1.03 | 453.60M | 441.60M |
| Q1 FY1996 | 31 Mar 1996 | 0.90 | 388.91M | 431.60M |
| Q4 FY1995 | 31 Dec 1995 | 0.95 | 392.88M | 412.90M |
| Q3 FY1995 | 30 Sept 1995 | 1.13 | 456.95M | 404.40M |
| Q2 FY1995 | 30 Jun 1995 | 1.20 | 468.46M | 390.70M |
| Q1 FY1995 | 31 Mar 1995 | 1.12 | 418.53M | 373.20M |
| Q4 FY1994 | 31 Dec 1994 | 1.23 | 450.20M | 365.10M |
| Q3 FY1994 | 30 Sept 1994 | 1.14 | 408.32M | 358.80M |
| Q2 FY1994 | 30 Jun 1994 | 0.98 | 345.32M | 353.30M |
| Q1 FY1994 | 31 Mar 1994 | 1.13 | 393.91M | 348.90M |
| Q4 FY1993 | 31 Dec 1993 | 1.12 | 390.09M | 348.70M |
| Q3 FY1993 | 30 Sept 1993 | 1.13 | 389.76M | 344.30M |
| Q2 FY1993 | 30 Jun 1993 | 1.07 | 369.46M | 343.70M |
| Q1 FY1993 | 31 Mar 1993 | 1.08 | 369.60M | 343.30M |
| Q4 FY1992 | 31 Dec 1992 | 1.05 | 353.63M | 338.20M |
| Q3 FY1992 | 30 Sept 1992 | 1.02 | 339.35M | 332.00M |
| Q2 FY1992 | 30 Jun 1992 | 1.10 | 363.38M | 330.30M |
| Q1 FY1992 | 31 Mar 1992 | 1.00 | 326.67M | 325.40M |
| Q4 FY1991 | 31 Dec 1991 | 0.84 | 278.54M | 329.70M |
| Q3 FY1991 | 30 Sept 1991 | 0.78 | 255.15M | 327.90M |
| Q2 FY1991 | 30 Jun 1991 | 0.75 | 243.48M | 325.20M |
| Q1 FY1991 | 31 Mar 1991 | 0.68 | 222.66M | 325.50M |
| Q4 FY1990 | 31 Dec 1990 | 0.60 | 193.02M | 323.20M |
| Q3 FY1990 | 30 Sept 1990 | 0.66 | 212.65M | 322.50M |
| Q2 FY1990 | 30 Jun 1990 | 0.88 | 275.82M | 315.00M |
| Q1 FY1990 | 31 Mar 1990 | 0.92 | 288.00M | 312.40M |
| Q4 FY1989 | 31 Dec 1989 | 0.98 | 304.00M | 308.70M |
| Q3 FY1989 | 30 Sept 1989 | 1.15 | 351.54M | 304.40M |
| Q2 FY1989 | 30 Jun 1989 | 0.99 | 301.99M | 304.00M |
| Q1 FY1989 | 31 Mar 1989 | 0.90 | 268.93M | 299.00M |
| Q4 FY1988 | 31 Dec 1988 | 0.84 | 243.30M | 288.20M |
| Q3 FY1988 | 30 Sept 1988 | 0.76 | 210.90M | 279.30M |
| Q2 FY1988 | 30 Jun 1988 | 0.87 | 232.92M | 267.30M |
| Q1 FY1988 | 31 Mar 1988 | 0.85 | 221.21M | 260.70M |
| Q4 FY1987 | 31 Dec 1987 | 1.07 | 271.81M | 253.30M |
| Q3 FY1987 | 30 Sept 1987 | 1.28 | 317.72M | 247.90M |
| Q2 FY1987 | 30 Jun 1987 | 1.32 | 327.42M | 247.90M |
| Q1 FY1987 | 31 Mar 1987 | 1.25 | 306.07M | 244.30M |
| Q4 FY1986 | 31 Dec 1986 | 0.95 | 223.89M | 235.60M |
| Q3 FY1986 | 30 Sept 1986 | 0.96 | 213.47M | 222.20M |
| Q2 FY1986 | 30 Jun 1986 | 1.14 | 237.87M | 207.90M |
| Q1 FY1986 | 31 Mar 1986 | — | 247.86M | — |
| Q4 FY1985 | 31 Dec 1985 | — | 204.76M | — |
| Q3 FY1985 | 30 Sept 1985 | — | 188.27M | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,Dividend yield,ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about West Pharmaceutical Services's P/S ratio
Source: Financial Modeling Prep